BMPR2 and pulmonary arterial hypertension: A genetic involvement is present in 6–10% of patients with PAH and most commonly involves the heterozygous germline mutation of the Bone Morphogenetic Protein Receptor (BMPR) gene, which encodes type 2 bone morphogenetic protein receptor (BMPR-2) [172].